Treatment of Hypoxic-Ischemic Brain Injury (HIBI)

1. Immediate Resuscitation (Restore Cardiorespiratory Function)

• Airway: Secure the airway immediately; intubate if necessary
• Oxygenation/ventilation: Ensure adequate oxygenation. Target SpO2 94-98% - avoid hyperoxia, as elevated cumulative oxygen tension is associated with worse functional outcomes
• Restore cerebral perfusion: CPR, IV fluids, vasopressors (norepinephrine is commonly used), or cardiac pacing as needed
• Target MAP >60 mmHg (systolic >90 mmHg). Higher perfusion targets may benefit patients with elevated ICP or intracranial stenosis, but benefit is not firmly established by trials
• 12-lead ECG immediately after ROSC; emergent cardiac catheterization if ST-elevation MI is identified
• Head CT (noncontrast) to exclude hemorrhagic stroke or subarachnoid hemorrhage presenting as cardiac arrest
• Harrison's Principles of Internal Medicine 22E (2025), p. 2390
• Plum and Posner's Diagnosis and Treatment of Stupor and Coma, p. 612

2. Targeted Temperature Management (TTM) - Neuroprotection

• Early trials showed mild hypothermia (33°C for 12-24 h) improved functional outcome after out-of-hospital cardiac arrest with shockable rhythms
• Subsequent larger trials (TTM trial) showed 33°C vs. 36°C yielded similar outcomes - suggesting the benefit may derive primarily from fever prevention rather than the degree of cooling
• A more recent trial found early fever treatment (target <37.8°C) resulted in similar outcomes to hypothermia to 33°C
• Current practice: target either 33°C or 36°C per institutional protocol, with strict fever avoidance

• Surface cooling: cold baths, ice packs, adhesive pads, helmets
• IV infusion of chilled fluids
• Endovascular temperature control devices (balloons with circulating cold fluid)
• Modern devices use real-time temperature feedback loops

• Counter-warming of hands/feet
• Acetaminophen 650 mg q4h PO
• Buspirone 30 mg q8h PO
• Sedation: propofol infusions (preferred) or benzodiazepines
• Analgesia: fentanyl or other opiate infusions
• Dexmedetomidine: potent anti-shivering agent
• Magnesium sulfate (target serum Mg 3-4 mEq/L)
• Meperidine 25 mg IV q6h (use cautiously - lowers seizure threshold)
• Neuromuscular blockade (vecuronium) as a last resort

• Plum and Posner's Diagnosis and Treatment of Stupor and Coma, pp. 613-615

3. Seizure Management

• Seizures occur in 10-30% of comatose post-arrest patients, most with status epilepticus (SE)
• Most common during rewarming; may be convulsive or nonconvulsive
• Continuous EEG monitoring is essential - nonconvulsive seizures will be missed clinically
• Treatment: levetiracetam, valproic acid, and benzodiazepines (e.g., clonazepam) are preferred in cardiac arrest patients
• Myoclonic status epilepticus within 24 h post-arrest is a poor prognostic sign, even when controlled
• Do not give prophylactic anticonvulsants routinely
• Complete suppression of all rhythmic/periodic EEG activity for 48 h (in a clinical trial) did not improve outcomes vs. standard care - this strategy is not recommended
• Post-hypoxic myoclonus: clonazepam 1.5-10 mg/day PO or valproate 300-1200 mg/day in divided doses
• Harrison's Principles of Internal Medicine 22E (2025), p. 2391
• Plum and Posner's Diagnosis and Treatment of Stupor and Coma, p. 614

4. Intracranial Pressure (ICP) Management

• Cerebral edema/swelling occurs in up to one-third of patients after cardiac arrest
• Managed using standard ICP protocols (head of bed elevation, osmotic therapy, etc.)
• Important caveat: brain swelling after cardiac arrest is a poor prognostic sign - it indicates extensive cortical neuronal loss, so decompressive craniectomy is generally not indicated
• Monitor carefully during rewarming for possible herniation
• Plum and Posner's Diagnosis and Treatment of Stupor and Coma, p. 615

5. Systemic/Medical Management

• Plum and Posner's Diagnosis and Treatment of Stupor and Coma, p. 615

6. Special Cases

• Carbon monoxide intoxication: hyperbaric oxygen is the treatment of choice for severe cases
• Both CO and cyanide can cause delayed encephalopathy - a parkinsonian syndrome (akinesia + rigidity without tremor) can develop weeks later, with progressive basal ganglia damage on CT/MRI

• Therapeutic hypothermia (whole-body or selective head cooling) is the established standard of care
• Multiple large RCTs support its use; xenon and argon as adjuncts are being investigated in preclinical and early clinical studies (PMID 39453983)

7. Prognostication

• Harrison's Principles of Internal Medicine 22E (2025), pp. 2389-2391

Summary Algorithm

HIBI suspected/confirmed
       |
       v
Restore airway + oxygenation (SpO2 94-98%) + circulation
       |
       v
ROSC achieved?
       |
       Yes
       v
12-lead ECG → STEMI → emergent cath
Head CT → exclude hemorrhage/SAH
       |
       v
Comatose (no response to verbal commands)?
       |
       Yes → TTM: target 32-37.5°C (commonly 33°C or 36°C)
              → Treat/prevent fever STRICTLY
              → Continuous EEG monitoring
              → Seizure management (levetiracetam, VPA, clonazepam)
              → Normoglycemia, electrolyte management
              → Lung-protective ventilation
              |
              v
       Multi-modal prognostication (earliest reliable: 5-7 days post-arrest,
       longer if hypothermia used)